In the current study, no statistically significant association was identified between Her2 expression and the different clinicopathological parameters, including age, gender, smoking, histological subtype, grade, stage, tumor size, lymph node status, and the predominant architectural pattern in ADC samples. This evidence concerns the gene ERBB2 and neoplasm.